Shell Asset Management CO Boston Scientific Corp Transaction History

Shell Asset Management CO

  • $2.27 Billion
  • Q3 2024

A detailed history of Shell Asset Management CO transactions in Boston Scientific Corp stock. As of the latest transaction made, Shell Asset Management CO holds 17,494 shares of BSX stock, worth $1.58 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
17,494
Previous 6,544 167.33%
Holding current value
$1.58 Million
Previous $504,000 190.87%
% of portfolio
0.06%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
BUY
$72.96 - $84.0 $798,911 - $919,800
10,950 Added 167.33%
17,494 $1.47 Million
Q1 2024

May 14, 2024
SELL
$57.6 - $68.62 $297,849 - $354,834
-5,171 Reduced 44.14%
6,544 $448,000
Q4 2023

Feb 14, 2024
SELL
$48.64 - $57.81 $362,222 - $430,511
-7,447 Reduced 38.86%
11,715 $677,000
Q3 2023

Nov 08, 2023
SELL
$50.19 - $54.68 $23,037 - $25,098
-459 Reduced 2.34%
19,162 $1.01 Million
Q2 2023

Jul 28, 2023
SELL
$49.72 - $54.64 $122,261 - $134,359
-2,459 Reduced 11.14%
19,621 $1.06 Million
Q1 2023

May 15, 2023
SELL
$45.09 - $50.03 $6,583 - $7,304
-146 Reduced 0.66%
22,080 $1.11 Million
Q4 2022

Feb 07, 2023
SELL
$39.56 - $47.22 $204,723 - $244,363
-5,175 Reduced 18.89%
22,226 $1.03 Million
Q3 2022

Nov 14, 2022
SELL
$36.71 - $109.66 $247,976 - $740,753
-6,755 Reduced 19.78%
27,401 $1.06 Million
Q2 2022

Aug 09, 2022
BUY
$35.24 - $47.1 $16,703 - $22,325
474 Added 1.41%
34,156 $1.27 Million
Q1 2022

May 04, 2022
BUY
$40.9 - $45.1 $54,928 - $60,569
1,343 Added 4.15%
33,682 $1.49 Million
Q4 2021

Feb 09, 2022
BUY
$38.07 - $44.87 $232,988 - $274,604
6,120 Added 23.34%
32,339 $1.37 Million
Q3 2021

Nov 04, 2021
SELL
$41.23 - $45.88 $100,972 - $112,360
-2,449 Reduced 8.54%
26,219 $1.14 Million
Q2 2021

Aug 12, 2021
SELL
$38.58 - $44.24 $1.17 Million - $1.34 Million
-30,205 Reduced 51.31%
28,668 $1.23 Million
Q1 2021

May 10, 2021
BUY
$35.27 - $39.67 $46,909 - $52,761
1,330 Added 2.31%
58,873 $2.28 Million
Q4 2020

Feb 16, 2021
BUY
$33.15 - $41.97 $152,722 - $193,355
4,607 Added 8.7%
57,543 $2.07 Million
Q3 2020

Nov 13, 2020
BUY
$34.44 - $42.23 $185,115 - $226,986
5,375 Added 11.3%
52,936 $2.02 Million
Q2 2020

Aug 10, 2020
SELL
$30.19 - $39.11 $1.17 Million - $1.52 Million
-38,915 Reduced 45.0%
47,561 $1.67 Million
Q1 2020

May 11, 2020
SELL
$25.83 - $45.71 $222,189 - $393,197
-8,602 Reduced 9.05%
86,476 $2.82 Million
Q4 2019

Feb 13, 2020
SELL
$37.87 - $45.37 $312,578 - $374,483
-8,254 Reduced 7.99%
95,078 $4.3 Million
Q3 2019

Nov 12, 2019
SELL
$40.31 - $43.45 $495,692 - $534,304
-12,297 Reduced 10.63%
103,332 $4.21 Million
Q2 2019

Aug 12, 2019
SELL
$34.91 - $42.98 $3.81 Million - $4.69 Million
-109,080 Reduced 48.54%
115,629 $4.97 Million
Q1 2019

May 09, 2019
BUY
$32.91 - $40.75 $3.41 Million - $4.22 Million
103,487 Added 85.37%
224,709 $8.62 Million
Q4 2018

Feb 13, 2019
SELL
$31.73 - $39.04 $1.36 Million - $1.67 Million
-42,801 Reduced 26.09%
121,222 $4.28 Million
Q3 2018

Nov 13, 2018
SELL
$32.83 - $38.63 $233,979 - $275,316
-7,127 Reduced 4.16%
164,023 $6.32 Million
Q2 2018

Aug 10, 2018
BUY
$26.84 - $34.32 $426,836 - $545,790
15,903 Added 10.24%
171,150 $5.6 Million
Q4 2017

Feb 09, 2018
BUY
$24.79 - $29.8 $332,681 - $399,916
13,420 Added 9.46%
155,247 $3.85 Million
Q3 2017

Oct 20, 2017
SELL
$26.26 - $29.17 $3.92 Million - $4.35 Million
-149,284 Reduced 51.28%
141,827 $4.14 Million
Q3 2017

Oct 18, 2017
BUY
$26.26 - $29.17 $7.64 Million - $8.49 Million
291,111
291,111 $3.44 Million

Others Institutions Holding BSX

# of Institutions
1,538
Shares Held
1.19B
Call Options Held
6.79M
Put Options Held
10.1M
View Full List

About BOSTON SCIENTIFIC CORP

BSX Quotes by TradingView
  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email